Sign in Subscribe
Diseases

Ultrasound Elastography in Prostate Diseases Diagnosis: Review of Current Status and Future Directions

Strategic Insights

— 2 min read

Research has highlighted the significance of prostate diseases, including prostate cancer and benign prostatic hyperplasia, which pose a substantial threat to men's health. Accurate and reliable diagnostic methods are crucial for early detection and timely intervention. Recent studies have demonstrated the efficacy of ultrasound elastography (UE) in diagnosing prostate diseases, showcasing its advantages in diagnostic accuracy and reduced invasiveness compared to conventional methods. However, challenges persist in translating UE into routine clinical practice, including standardized protocols, variability in result interpretation, and limited equipment availability.

Key Takeaways:

  • Prostate diseases, including prostate cancer and benign prostatic hyperplasia, are significant threats to men's health, emphasizing the need for accurate and reliable diagnostic methods.
  • Ultrasound elastography (UE) has demonstrated efficacy in diagnosing prostate diseases, with advantages in diagnostic accuracy and reduced invasiveness compared to conventional methods.
  • Challenges in translating UE into routine clinical practice include the lack of standardized protocols, variability in result interpretation, and limited equipment availability.
  • UE has broad application prospects in the diagnosis and treatment monitoring of prostate diseases, according to numerous studies that have validated its clinical potential.
  • The Shanghai Punan Hospital has considered the impact of UE on clinical practice, recognizing its potential to revolutionize the diagnosis and treatment of prostate diseases.
  • The Journal of Clinical Ultrasound has published research on UE in prostate diseases, demonstrating its clinical utility and highlighting future directions for research and clinical applications.
  • Yunxin Zhao, a researcher at Shanghai Punan Hospital, has emphasized the importance of standardizing UE protocols and improving equipment availability to facilitate its widespread adoption.

Statistics:

  • Prostate cancer affects approximately 1 in 8 men in their lifetime, with a 5-year survival rate of 92% for men diagnosed in the early stages (National Cancer Institute).
  • Benign prostatic hyperplasia affects up to 50% of men over the age of 50, with a significant impact on quality of life (European Urology Association).
  • Ultrasound elastography (UE) has demonstrated a diagnostic accuracy of 92% for prostate diseases compared to conventional imaging modalities (Journal of Clinical Ultrasound).
  • The Journal of Clinical Ultrasound has published research on UE in prostate diseases, with a total of 5 articles published between 2020 and 2025 (onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0096).

Sources:

  • NewsRx. Shanghai Punan Hospital Reports Findings in Engineering (Ultrasound Elastography in Prostate Diseases: Current Status and Future Directions-A Review). Journal of Engineering. July 7, 2025; p 4660.
  • Journal of Clinical Ultrasound. Ultrasound Elastography in Prostate Diseases: Current Status and Future Directions-A Review. Wiley, 2025.

Read more